Large-diameter penetrating keratoplasty: Indications and outcomes

Cornea

Volumn 29, Issue 3, 2010, Pages 296-301

  Skeens, Heather M ^a   Holland, Edward J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

High risk keratoplasty; Keratoplasty outcomes; Penetrating keratoplasty

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A;

ADULT; AGED; ARTICLE; ASTIGMATISM; CATARACT; CLINICAL ARTICLE; CONGENITAL CORNEA DYSTROPHY; CORNEA DISEASE; CORNEA STROMA; CORNEA TRANSPLANTATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRREGULAR ASTIGMATISM; KERATITIS; KERATOCONUS; KERATOTOMY; LARGE DIAMETER PENETRATING KERATOPLASTY; MALE; MEDICAL RECORD REVIEW; PENETRATING KERATOPLASTY; POSTOPERATIVE ASTIGMATISM; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SECONDARY GLAUCOMA; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ASTIGMATISM; CORNEA; CORNEAL DISEASES; FEMALE; GRAFT REJECTION; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77649098245     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181b6489e     Document Type: Article

References (23)

1. CCTS Research Group. The Collaborative Corneal Transplantation Studies. Arch Ophthalmol. 1992;110:1392-1403.
2. Mader T, Stulting D. The high-risk penetrating keratoplasty. Ophthalmol Clin North Am. 1991;4:411-422.
3. Cowden J, Copeland R, Schneider M. Large diameter therapeutic penetrating keratoplasties. J Refract Corneal Surg. 1989;5:244-248.
4. Cherry PMH, Pashby RC, Tadros ML, et al. An analysis of corneal transplantation. Ann Ophthalmol. 1979;11:461-469.
5. Tuberville AW, Foster CS, Wood TO. The effect of donor cornea epithelium removal on the incidence of allograft rejection reactions. Ophthalmology. 1983;90:1351-1356.
6. Kaufman HE, Barron BA, Mc Donald MB, et al. The Cornea. New York: Churchill Livingstone; 1988.
7. Jensen AD, Maumenee AE. Refractive errors following keratoplasty. Trans Am Ophthalmol Soc. 1974;72:123-131.
8. Krachmer JH, Mannis MJ, Holland EJ. Cornea. Philadelphia: Elsevier Mosby; 2005.
9. Speaker M, Arentsen J, Laibson P. Long-term survival of large diameter penetrating keratoplasties for keratoconus and pellucid marginal degeneration. Acta Ophthalmol. 1989;67:17-19.
10. Kirkness CM, Ficker LA, Rice NSC, et al. Large corneal grafts can be successful. Eye. 1989;3:48-55.
11. Kuckelkorn R, Redbrake C, Schrage NF, et al. Keratoplasty with 11-12 mm diameter for management of severely chemical-burned eyes. Ophthalmologe. 1993;90:683-687.
12. Bourges JL, Lallemand F, Agla E, et al. Evaluation of topical cyclosporine A prodrug on corneal graft rejection in rats. Mol Vis. 2006;12:1461-1466.
13. Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporine A in the treatment of anterior segment inflammatory disease. Cornea. 1993;12: 413-419.
14. Xi X, Qin B, Jiang DY. Cyclosporine A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty. Hunan Yi Ke Da Xue Xue Bao. 2003;28:627-630.
15. Cosar CB, Laibson PR, Cohen EJ, et al. Topical cyclosporine in pediatric keratoplasty. Eye Contact Lens. 2003;29:103-107.
16. Inoue K, Amano S, Kimura C, et al. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:302-305.
17. Perry HD, Doshi SJ, Donnenfeld ED, et al. Topical cyclosporine A in the management of therapeutic keratoplasty for mycotic keratitis. Cornea. 2002;21:161-163.
18. Sonmez B, Beden U, Erkan D. Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer. Int Ophthalmol. 2009;29: 123-125.
19. Price MO, Price FW. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology. 2006;113:1785-1790.
20. Randleman BJ, Stulting DR. Prevention and treatment of corneal graft rejection: current practice patterns 2004. Cornea. 2006;25: 286-290.
21. Unal M, Yucel I. Evaluation of topical cyclosporine 0.05% for prevention of rejection in high risk corneal grafts. Br J Ophthalmol. 2008;92: 1411-1414.
22. Seitz B, Langenbucher A, Nguyen NX, et al. Long-term follow-up of intraocular pressure after penetrating keratoplasty for keratoconus and Fuchs' dystrophy: comparison of mechanical and excimer laser trephination. Cornea. 2002;21:368-373.
23. Rathi VM, Krishnamachary M, Gupta S. Cataract formation after penetrating keratoplasty. J Cataract Refract Surg. 1997;23:562-564.